Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Public ClinicalTrials.gov record NCT05972135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05972135
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- SCRI Development Innovations, LLC
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Oral Dexamethasone Drug
- Talquetamab Drug
- Teclistamab Drug
- Tocilizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 22, 2023
- Primary completion
- Jul 31, 2027
- Completion
- Sep 30, 2027
- Last update posted
- Apr 21, 2026
2023 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates | Tucson | Arizona | 85711 | Recruiting |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | Recruiting |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | Recruiting |
| Medical Oncology Hematology Consultants | Newark | Delaware | 19713 | Recruiting |
| Florida Cancer Specialists | Lake Mary | Florida | 32746 | Withdrawn |
| Maryland Oncology Hematology | Columbia | Maryland | 21044 | Recruiting |
| Minnesota Oncology Hematology | Minneapolis | Minnesota | 55404 | Recruiting |
| Virginia Oncology Associates | Elizabeth City | North Carolina | 27909 | Recruiting |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | Recruiting |
| Oncology Associates of Oregon | Eugene | Oregon | 97401 | Recruiting |
| TriStar Bone Marrow Transplant | Nashville | Tennessee | 37203 | Recruiting |
| Vanderbilt- Ingram Cancer Center | Nashville | Tennessee | 37232 | Recruiting |
| Texas Oncology | Austin | Texas | 78705 | Recruiting |
| Texas Oncology - San Antonio | San Antonio | Texas | 78240 | Recruiting |
| Texas Oncology - Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | Recruiting |
| Blue Ridge Cancer Center | Roanoke | Virginia | 24014 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05972135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05972135 live on ClinicalTrials.gov.